株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界における合成生物学市場

Global Synthetic Biology Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 308330
出版日 ページ情報 英文 74 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界における合成生物学市場 Global Synthetic Biology Market 2014-2018
出版日: 2014年07月14日 ページ情報: 英文 74 Pages
概要

世界における合成生物学市場は、2013年から2018年にかけて、33.8%の年間複合成長率(CAGR)で拡大することが見込まれています。

当レポートでは、世界における合成生物学市場の現状分析と将来予測、技術、製品、アプリケーション、地域別の動向、成長因子と課題、主要企業のプロファイルなどを提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 製品とサービス

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 技術別の市場区分

第8章 製品別の市場区分

第9章 アプリケーション別の市場区分

第10章 地理区分

  • 南北アメリカ
  • EMEA
  • アジア太平洋地域

第11章 購入基準

第12章 市場成長因子

第13章 成長因子とその影響

第14章 市場の課題

第15章 成長因子と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • ベンダーシェア分析
  • その他の有力ベンダー

第19章 主要ベンダーの分析

  • Amyris Inc.
  • E. I. du Pont de Nemours and Company
  • Synthetic Genomics, Inc.
  • Thermo Fisher Scientific Inc.

第20章 関連レポート

目次
Product Code: IRTNTR3818

About Synthetic Biology

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.

TechNavio's analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.

Covered in this Report

The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.

TechNavio's report, the Global Synthetic Biology Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Synthetic Biology market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Amyris Inc.
  • E. I. du Pont de Nemours and Co.
  • Thermo Fisher Scientific Inc.
  • Synthetic Genomics Inc.

Other Prominent Vendors

  • Algenol Biofuels Inc.
  • ATG:biosynthetics GmbH
  • Bayer AG
  • Bioneer Corp.
  • Biosearch Technologies Inc.
  • Bristol-Myers Squibb Co.
  • CBC Comprehensive Biomarker Center GmbH
  • Cobalt Technologies
  • Evolva Holdings SA
  • Exxon Mobil Corp.
  • GeneWorks Pty Ltd.
  • Genomatica Inc.
  • Gevo Inc.
  • Ginkgo Bioworks
  • Green Biologics Ltd.
  • New England Biolabs Inc.
  • OriGene Technologies Inc.
  • REG Life Sciences LLC
  • Royal DSM
  • Synthorx Inc.

Key Market Driver

  • Increased R&D in Synthetic Biology

For a full, detailed list, view our report.

Key Market Challenge

  • Lack of Modularized Biological Parts

For a full, detailed list, view our report.

Key Market Trend

  • Growing Demand for GM Crops

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product and Service Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Product

09. Market Segmentation by Applications

10. Geographical Segmentation

  • 10.1. Synthetic Biology Market in the Americas
    • 10.1.1. Market Size and Forecast
  • 10.2. Synthetic Biology Market in the EMEA Region
    • 10.2.1. Market Size and Forecast
  • 10.3. Synthetic Biology Market in the APAC Region
    • 10.3.1. Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Vendor Share Analysis 2013
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Amyris Inc.
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Strategy
    • 19.1.4. Geographical Segmentation
    • 19.1.5. Key Developments
    • 19.1.6. SWOT Analysis
    • 19.1.7. Strengths
    • 19.1.8. Weakness
    • 19.1.9. Opportunities
    • 19.1.10. Threats
  • 19.2. E. I. du Pont de Nemours and Company
    • 19.2.1. Key Facts
    • 19.2.2. Business Description
    • 19.2.3. Business Segmentation
    • 19.2.4. Business Strategy
    • 19.2.5. Revenue Segmentation
    • 19.2.6. Revenue Comparison 2013-2011
    • 19.2.7. Geographical Segmentation
    • 19.2.8. Key Developments
    • 19.2.9. SWOT Analysis
    • 19.2.10. Strengths
    • 19.2.11. Weakness
    • 19.2.12. Opportunities
    • 19.2.13. Threats
  • 19.3. Synthetic Genomics, Inc.
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview/ Description
    • 19.3.3. Business Strategy
    • 19.3.4. Key Information
    • 19.3.5. SWOT Analysis
    • 19.3.6. Strengths
    • 19.3.7. Weakness
    • 19.3.8. Opportunities
    • 19.3.9. Threats
  • 19.4. Thermo Fisher Scientific Inc.
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation
    • 19.4.4. Revenue Segmentation by Business
    • 19.4.5. Revenue Segmentation by Products
    • 19.4.6. Sales by Geographical Segmentation
    • 19.4.7. Business Strategy
    • 19.4.8. Key Information
    • 19.4.9. SWOT Analysis
    • 19.4.10. Strengths
    • 19.4.11. Weaknesses
    • 19.4.12. Opportunities
    • 19.4.13. Threats

20. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Synthetic Biology Market 2013-2018 (US$ million)
  • Exhibit 3: Global Synthetic Biology Market Segmentation by Technology
  • Exhibit 4: Global Synthetic Biology Market Segmentation by Technology 2013
  • Exhibit 5: Global Synthetic Biology Market Segmentation by Product
  • Exhibit 6: Global Synthetic Biology Market Segmentation by Applications
  • Exhibit 7: Global Synthetic Biology Market Segmentation by Applications 2013
  • Exhibit 8: Global Synthetic Biology Market by Geographical Segmentation 2013
  • Exhibit 9: Synthetic Biology Market in the Americas 2013-2018 (US$ million)
  • Exhibit 10: Synthetic Biology Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 11: Synthetic Biology Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 12: Number of Entities Conducting Research in the Global Synthetic Biology Market 2013
  • Exhibit 13: Amyris Inc.: Segmentation by Geography 2013
  • Exhibit 14: Amyris Inc.: Revenue Comparison by Geographical Segmentation 2013-2011 (US$ million)
  • Exhibit 15: Business Segmentation of DuPont: 2013
  • Exhibit 16: Revenue Segmentation of DuPont 2013
  • Exhibit 17: DuPont:Revenue Comparison by business segments for 2013-2011(US$ million)
  • Exhibit 18: DuPont by Geographical Segmentation 2013
  • Exhibit 19: DuPont Revenue Comparison by Geography segments for 2013-2011 (US$ million)
  • Exhibit 20: Business Segmentation of Thermo Fisher Scientific Inc.
  • Exhibit 21: Revenue by Business Segments of Thermo Fisher Scientific Inc. 2013
  • Exhibit 22: Revenue by Products of Thermo Fisher Scientific Inc. 2013
  • Exhibit 23: Sales by Geographical Segmentation of Thermo Fisher Scientific Inc. 2013
Back to Top